位置:首页 > 蛋白库 > ACM3_HUMAN
ACM3_HUMAN
ID   ACM3_HUMAN              Reviewed;         590 AA.
AC   P20309; Q0VAJ8; Q4QRI3; Q5VXY2; Q9HB60;
DT   01-FEB-1991, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1991, sequence version 1.
DT   03-AUG-2022, entry version 209.
DE   RecName: Full=Muscarinic acetylcholine receptor M3;
GN   Name=CHRM3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=3443095; DOI=10.1002/j.1460-2075.1987.tb02733.x;
RA   Peralta E.G., Ashkenazi A., Winslow J.W., Smith D.H., Ramachandran J.,
RA   Capon D.J.;
RT   "Distinct primary structures, ligand-binding properties and tissue-specific
RT   expression of four human muscarinic acetylcholine receptors.";
RL   EMBO J. 6:3923-3929(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=3272174; DOI=10.1016/0896-6273(88)90190-0;
RA   Bonner T.I., Young A.C., Brann M.R., Buckley N.J.;
RT   "Cloning and expression of the human and rat m5 muscarinic acetylcholine
RT   receptor genes.";
RL   Neuron 1:403-410(1988).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=15014171; DOI=10.1093/molbev/msh100;
RA   Kitano T., Liu Y.-H., Ueda S., Saitou N.;
RT   "Human-specific amino acid changes found in 103 protein-coding genes.";
RL   Mol. Biol. Evol. 21:936-944(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RA   Puhl H.L. III, Ikeda S.R., Aronstam R.S.;
RT   "cDNA clones of human proteins involved in signal transduction sequenced by
RT   the Guthrie cDNA resource center (www.cdna.org).";
RL   Submitted (APR-2002) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-384.
RC   TISSUE=Teratocarcinoma;
RX   PubMed=11238933; DOI=10.1128/mcb.21.6.1973-1985.2001;
RA   Speek M.;
RT   "Antisense promoter of human L1 retrotransposon drives transcription of
RT   adjacent cellular genes.";
RL   Mol. Cell. Biol. 21:1973-1985(2001).
RN   [8]
RP   FUNCTION.
RX   PubMed=7565628;
RA   Yang J., Williams J.A., Yule D.I., Logsdon C.D.;
RT   "Mutation of carboxyl-terminal threonine residues in human M3 muscarinic
RT   acetylcholine receptor modulates the extent of sequestration and
RT   desensitization.";
RL   Mol. Pharmacol. 48:477-485(1995).
RN   [9]
RP   INVOLVEMENT IN PBS.
RX   PubMed=22077972; DOI=10.1016/j.ajhg.2011.10.007;
RA   Weber S., Thiele H., Mir S., Toliat M.R., Sozeri B., Reutter H.,
RA   Draaken M., Ludwig M., Altmuller J., Frommolt P., Stuart H.M., Ranjzad P.,
RA   Hanley N.A., Jennings R., Newman W.G., Wilcox D.T., Thiel U.,
RA   Schlingmann K.P., Beetz R., Hoyer P.F., Konrad M., Schaefer F.,
RA   Nurnberg P., Woolf A.S.;
RT   "Muscarinic acetylcholine receptor M3 mutation causes urinary bladder
RT   disease and a prune-belly-like syndrome.";
RL   Am. J. Hum. Genet. 89:668-674(2011).
RN   [10]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH TMEM147.
RX   PubMed=21056967; DOI=10.1124/mol.110.067363;
RA   Rosemond E., Rossi M., McMillin S.M., Scarselli M., Donaldson J.G.,
RA   Wess J.;
RT   "Regulation of M(3) muscarinic receptor expression and function by
RT   transmembrane protein 147.";
RL   Mol. Pharmacol. 79:251-261(2011).
RN   [11]
RP   SUBUNIT, AND SUBCELLULAR LOCATION.
RX   PubMed=23521066; DOI=10.1042/bj20121902;
RA   Patowary S., Alvarez-Curto E., Xu T.R., Holz J.D., Oliver J.A.,
RA   Milligan G., Raicu V.;
RT   "The muscarinic M3 acetylcholine receptor exists as two differently sized
RT   complexes at the plasma membrane.";
RL   Biochem. J. 452:303-312(2013).
RN   [12]
RP   STRUCTURE BY NMR OF 271-289, MUTAGENESIS OF GLU-276; PHE-280 AND VAL-281,
RP   AND SUBCELLULAR LOCATION.
RX   PubMed=15870063; DOI=10.1074/jbc.m501264200;
RA   Iverson H.A., Fox D. III, Nadler L.S., Klevit R.E., Nathanson N.M.;
RT   "Identification and structural determination of the M(3) muscarinic
RT   acetylcholine receptor basolateral sorting signal.";
RL   J. Biol. Chem. 280:24568-24575(2005).
CC   -!- FUNCTION: The muscarinic acetylcholine receptor mediates various
CC       cellular responses, including inhibition of adenylate cyclase,
CC       breakdown of phosphoinositides and modulation of potassium channels
CC       through the action of G proteins. Primary transducing effect is Pi
CC       turnover. {ECO:0000269|PubMed:7565628}.
CC   -!- SUBUNIT: Homodimer; the dimers can form tetramers (PubMed:23521066).
CC       Interacts with NALCN (By similarity). Interacts with TMEM147
CC       (PubMed:21056967). {ECO:0000250|UniProtKB:Q9ERZ3,
CC       ECO:0000269|PubMed:21056967, ECO:0000269|PubMed:23521066}.
CC   -!- INTERACTION:
CC       P20309; P08912: CHRM5; NbExp=7; IntAct=EBI-2687785, EBI-6655256;
CC       P20309; Q8IZF0: NALCN; NbExp=3; IntAct=EBI-2687785, EBI-7085333;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:21056967};
CC       Multi-pass membrane protein {ECO:0000255}. Postsynaptic cell membrane;
CC       Multi-pass membrane protein {ECO:0000255}. Basolateral cell membrane
CC       {ECO:0000269|PubMed:15870063}; Multi-pass membrane protein
CC       {ECO:0000255}. Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:21056967}; Multi-pass membrane protein
CC       {ECO:0000255}. Note=Colocalizes with TMEM147 in the endoplasmic
CC       reticulum (ER) membrane. TMEM147 impairs its trafficking to the cell
CC       membrane leading to its retention in the ER membrane.
CC       {ECO:0000269|PubMed:21056967}.
CC   -!- DISEASE: Prune belly syndrome (PBS) [MIM:100100]: A syndrome
CC       characterized by thin abdominal musculature with overlying lax skin,
CC       cryptorchism, megacystis with disorganized detrusor muscle, and urinary
CC       tract abnormalities. {ECO:0000269|PubMed:22077972}. Note=The disease is
CC       caused by variants affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family.
CC       Muscarinic acetylcholine receptor subfamily. CHRM3 sub-subfamily.
CC       {ECO:0000255|PROSITE-ProRule:PRU00521}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X15266; CAA33337.1; -; Genomic_DNA.
DR   EMBL; U29589; AAA70337.1; -; Genomic_DNA.
DR   EMBL; AB041395; BAA94480.1; -; Genomic_DNA.
DR   EMBL; AF498917; AAM18940.1; -; mRNA.
DR   EMBL; AL356361; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC096844; AAH96844.1; -; mRNA.
DR   EMBL; BC121026; AAI21027.1; -; mRNA.
DR   EMBL; AF279779; AAG30036.1; -; mRNA.
DR   CCDS; CCDS1616.1; -.
DR   PIR; S10128; S10128.
DR   RefSeq; NP_000731.1; NM_000740.3.
DR   RefSeq; NP_001334645.1; NM_001347716.1.
DR   RefSeq; XP_005273089.1; XM_005273032.3.
DR   RefSeq; XP_011542343.1; XM_011544041.2.
DR   RefSeq; XP_011542345.1; XM_011544043.2.
DR   RefSeq; XP_011542346.1; XM_011544044.2.
DR   RefSeq; XP_011542348.1; XM_011544046.2.
DR   RefSeq; XP_011542349.1; XM_011544047.2.
DR   RefSeq; XP_016855641.1; XM_017000152.1.
DR   RefSeq; XP_016855642.1; XM_017000153.1.
DR   RefSeq; XP_016855643.1; XM_017000154.1.
DR   RefSeq; XP_016855644.1; XM_017000155.1.
DR   RefSeq; XP_016855645.1; XM_017000156.1.
DR   RefSeq; XP_016855646.1; XM_017000157.1.
DR   RefSeq; XP_016855647.1; XM_017000158.1.
DR   RefSeq; XP_016855648.1; XM_017000159.1.
DR   RefSeq; XP_016855649.1; XM_017000160.1.
DR   RefSeq; XP_016855650.1; XM_017000161.1.
DR   RefSeq; XP_016855651.1; XM_017000162.1.
DR   RefSeq; XP_016855652.1; XM_017000163.1.
DR   PDB; 2CSA; NMR; -; A=271-289.
DR   PDBsum; 2CSA; -.
DR   AlphaFoldDB; P20309; -.
DR   SMR; P20309; -.
DR   BioGRID; 107553; 80.
DR   DIP; DIP-44291N; -.
DR   IntAct; P20309; 65.
DR   MINT; P20309; -.
DR   STRING; 9606.ENSP00000255380; -.
DR   BindingDB; P20309; -.
DR   ChEMBL; CHEMBL245; -.
DR   DrugBank; DB03128; Acetylcholine.
DR   DrugBank; DB08897; Aclidinium.
DR   DrugBank; DB05752; ALKS 27.
DR   DrugBank; DB00321; Amitriptyline.
DR   DrugBank; DB00543; Amoxapine.
DR   DrugBank; DB00517; Anisotropine methylbromide.
DR   DrugBank; DB04365; Arecoline.
DR   DrugBank; DB01238; Aripiprazole.
DR   DrugBank; DB14185; Aripiprazole lauroxil.
DR   DrugBank; DB00572; Atropine.
DR   DrugBank; DB00767; Benzquinamide.
DR   DrugBank; DB01019; Bethanechol.
DR   DrugBank; DB00835; Brompheniramine.
DR   DrugBank; DB09300; Butylscopolamine.
DR   DrugBank; DB00411; Carbamoylcholine.
DR   DrugBank; DB00185; Cevimeline.
DR   DrugBank; DB00477; Chlorpromazine.
DR   DrugBank; DB01239; Chlorprothixene.
DR   DrugBank; DB00568; Cinnarizine.
DR   DrugBank; DB00363; Clozapine.
DR   DrugBank; DB00434; Cyproheptadine.
DR   DrugBank; DB00496; Darifenacin.
DR   DrugBank; DB01151; Desipramine.
DR   DrugBank; DB00804; Dicyclomine.
DR   DrugBank; DB13720; Diphemanil.
DR   DrugBank; DB01231; Diphenidol.
DR   DrugBank; DB00280; Disopyramide.
DR   DrugBank; DB09167; Dosulepin.
DR   DrugBank; DB01142; Doxepin.
DR   DrugBank; DB00366; Doxylamine.
DR   DrugBank; DB09194; Etoperidone.
DR   DrugBank; DB06702; Fesoterodine.
DR   DrugBank; DB00986; Glycopyrronium.
DR   DrugBank; DB00502; Haloperidol.
DR   DrugBank; DB06787; Hexocyclium.
DR   DrugBank; DB11181; Homatropine.
DR   DrugBank; DB00725; Homatropine methylbromide.
DR   DrugBank; DB00424; Hyoscyamine.
DR   DrugBank; DB09262; Imidafenacin.
DR   DrugBank; DB00458; Imipramine.
DR   DrugBank; DB00332; Ipratropium.
DR   DrugBank; DB01625; Isopropamide.
DR   DrugBank; DB01221; Ketamine.
DR   DrugBank; DB00408; Loxapine.
DR   DrugBank; DB00934; Maprotiline.
DR   DrugBank; DB04843; Mepenzolate.
DR   DrugBank; DB00454; Meperidine.
DR   DrugBank; DB06709; Methacholine.
DR   DrugBank; DB00940; Methantheline.
DR   DrugBank; DB01403; Methotrimeprazine.
DR   DrugBank; DB00462; Methscopolamine bromide.
DR   DrugBank; DB00340; Metixene.
DR   DrugBank; DB01226; Mivacurium.
DR   DrugBank; DB00622; Nicardipine.
DR   DrugBank; DB00540; Nortriptyline.
DR   DrugBank; DB00334; Olanzapine.
DR   DrugBank; DB01062; Oxybutynin.
DR   DrugBank; DB00383; Oxyphencyclimine.
DR   DrugBank; DB01337; Pancuronium.
DR   DrugBank; DB00715; Paroxetine.
DR   DrugBank; DB01085; Pilocarpine.
DR   DrugBank; DB01338; Pipecuronium.
DR   DrugBank; DB06153; Pizotifen.
DR   DrugBank; DB00387; Procyclidine.
DR   DrugBank; DB01069; Promethazine.
DR   DrugBank; DB00777; Propiomazine.
DR   DrugBank; DB12278; Propiverine.
DR   DrugBank; DB01224; Quetiapine.
DR   DrugBank; DB11855; Revefenacin.
DR   DrugBank; DB13581; Rociverine.
DR   DrugBank; DB00747; Scopolamine.
DR   DrugBank; DB01591; Solifenacin.
DR   DrugBank; DB00202; Succinylcholine.
DR   DrugBank; DB00342; Terfenadine.
DR   DrugBank; DB00599; Thiopental.
DR   DrugBank; DB11235; Thonzylamine.
DR   DrugBank; DB01409; Tiotropium.
DR   DrugBank; DB01036; Tolterodine.
DR   DrugBank; DB00193; Tramadol.
DR   DrugBank; DB00505; Tridihexethyl.
DR   DrugBank; DB00376; Trihexyphenidyl.
DR   DrugBank; DB09089; Trimebutine.
DR   DrugBank; DB00726; Trimipramine.
DR   DrugBank; DB00809; Tropicamide.
DR   DrugBank; DB00209; Trospium.
DR   DrugBank; DB09076; Umeclidinium.
DR   DrugBank; DB00246; Ziprasidone.
DR   DrugCentral; P20309; -.
DR   GuidetoPHARMACOLOGY; 15; -.
DR   GlyGen; P20309; 5 sites.
DR   iPTMnet; P20309; -.
DR   PhosphoSitePlus; P20309; -.
DR   BioMuta; CHRM3; -.
DR   DMDM; 113125; -.
DR   jPOST; P20309; -.
DR   MassIVE; P20309; -.
DR   MaxQB; P20309; -.
DR   PaxDb; P20309; -.
DR   PeptideAtlas; P20309; -.
DR   PRIDE; P20309; -.
DR   ProteomicsDB; 53745; -.
DR   Antibodypedia; 4169; 376 antibodies from 37 providers.
DR   DNASU; 1131; -.
DR   Ensembl; ENST00000255380.8; ENSP00000255380.4; ENSG00000133019.12.
DR   Ensembl; ENST00000615928.5; ENSP00000482377.1; ENSG00000133019.12.
DR   Ensembl; ENST00000675184.1; ENSP00000502349.1; ENSG00000133019.12.
DR   Ensembl; ENST00000676153.1; ENSP00000502667.1; ENSG00000133019.12.
DR   Ensembl; ENST00000676433.1; ENSP00000502013.1; ENSG00000133019.12.
DR   GeneID; 1131; -.
DR   KEGG; hsa:1131; -.
DR   MANE-Select; ENST00000676153.1; ENSP00000502667.1; NM_001375978.1; NP_001362907.1.
DR   UCSC; uc001hyp.4; human.
DR   CTD; 1131; -.
DR   DisGeNET; 1131; -.
DR   GeneCards; CHRM3; -.
DR   HGNC; HGNC:1952; CHRM3.
DR   HPA; ENSG00000133019; Tissue enhanced (brain, salivary gland).
DR   MalaCards; CHRM3; -.
DR   MIM; 100100; phenotype.
DR   MIM; 118494; gene.
DR   neXtProt; NX_P20309; -.
DR   OpenTargets; ENSG00000133019; -.
DR   Orphanet; 2970; Prune belly syndrome.
DR   PharmGKB; PA112; -.
DR   VEuPathDB; HostDB:ENSG00000133019; -.
DR   eggNOG; KOG4220; Eukaryota.
DR   GeneTree; ENSGT00940000160084; -.
DR   HOGENOM; CLU_009579_11_2_1; -.
DR   InParanoid; P20309; -.
DR   OMA; ISASWIH; -.
DR   OrthoDB; 1245472at2759; -.
DR   PhylomeDB; P20309; -.
DR   TreeFam; TF320495; -.
DR   PathwayCommons; P20309; -.
DR   Reactome; R-HSA-390648; Muscarinic acetylcholine receptors.
DR   Reactome; R-HSA-399997; Acetylcholine regulates insulin secretion.
DR   Reactome; R-HSA-416476; G alpha (q) signalling events.
DR   SignaLink; P20309; -.
DR   SIGNOR; P20309; -.
DR   BioGRID-ORCS; 1131; 8 hits in 1075 CRISPR screens.
DR   ChiTaRS; CHRM3; human.
DR   EvolutionaryTrace; P20309; -.
DR   GeneWiki; Muscarinic_acetylcholine_receptor_M3; -.
DR   GenomeRNAi; 1131; -.
DR   Pharos; P20309; Tclin.
DR   PRO; PR:P20309; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; P20309; protein.
DR   Bgee; ENSG00000133019; Expressed in endothelial cell and 154 other tissues.
DR   ExpressionAtlas; P20309; baseline and differential.
DR   Genevisible; P20309; HS.
DR   GO; GO:0070161; C:anchoring junction; IEA:UniProtKB-KW.
DR   GO; GO:0009925; C:basal plasma membrane; IDA:ARUK-UCL.
DR   GO; GO:0016323; C:basolateral plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0030425; C:dendrite; IBA:GO_Central.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005887; C:integral component of plasma membrane; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0045202; C:synapse; IBA:GO_Central.
DR   GO; GO:0042166; F:acetylcholine binding; ISS:UniProtKB.
DR   GO; GO:0016907; F:G protein-coupled acetylcholine receptor activity; ISS:UniProtKB.
DR   GO; GO:0004993; F:G protein-coupled serotonin receptor activity; IBA:GO_Central.
DR   GO; GO:0030594; F:neurotransmitter receptor activity; IBA:GO_Central.
DR   GO; GO:0004435; F:phosphatidylinositol phospholipase C activity; TAS:ProtInc.
DR   GO; GO:0038023; F:signaling receptor activity; TAS:ProtInc.
DR   GO; GO:0095500; P:acetylcholine receptor signaling pathway; IDA:ARUK-UCL.
DR   GO; GO:0007197; P:adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway; IBA:GO_Central.
DR   GO; GO:0019722; P:calcium-mediated signaling; IDA:ARUK-UCL.
DR   GO; GO:0007268; P:chemical synaptic transmission; IBA:GO_Central.
DR   GO; GO:0007213; P:G protein-coupled acetylcholine receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0007186; P:G protein-coupled receptor signaling pathway; TAS:ProtInc.
DR   GO; GO:0007187; P:G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; IBA:GO_Central.
DR   GO; GO:0007399; P:nervous system development; TAS:ProtInc.
DR   GO; GO:0045987; P:positive regulation of smooth muscle contraction; IEA:Ensembl.
DR   GO; GO:0036211; P:protein modification process; TAS:ProtInc.
DR   GO; GO:0032412; P:regulation of ion transmembrane transporter activity; IDA:ARUK-UCL.
DR   GO; GO:0003056; P:regulation of vascular associated smooth muscle contraction; IBA:GO_Central.
DR   GO; GO:0046541; P:saliva secretion; IEA:Ensembl.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   GO; GO:0006939; P:smooth muscle contraction; IEA:Ensembl.
DR   InterPro; IPR000276; GPCR_Rhodpsn.
DR   InterPro; IPR017452; GPCR_Rhodpsn_7TM.
DR   InterPro; IPR001183; Musac_Ach_M3_rcpt.
DR   InterPro; IPR000995; Musac_Ach_rcpt.
DR   Pfam; PF00001; 7tm_1; 1.
DR   PRINTS; PR00237; GPCRRHODOPSN.
DR   PRINTS; PR00243; MUSCARINICR.
DR   PRINTS; PR00540; MUSCRINICM3R.
DR   SMART; SM01381; 7TM_GPCR_Srsx; 1.
DR   PROSITE; PS00237; G_PROTEIN_RECEP_F1_1; 1.
DR   PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell membrane; Disulfide bond; Endoplasmic reticulum;
KW   G-protein coupled receptor; Glycoprotein; Membrane; Phosphoprotein;
KW   Postsynaptic cell membrane; Receptor; Reference proteome; Synapse;
KW   Transducer; Transmembrane; Transmembrane helix.
FT   CHAIN           1..590
FT                   /note="Muscarinic acetylcholine receptor M3"
FT                   /id="PRO_0000069029"
FT   TOPO_DOM        1..67
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        68..91
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        92..104
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        105..130
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        131..142
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        143..164
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        165..184
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        185..206
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        207..229
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        230..252
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        253..491
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        492..514
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        515..526
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        527..546
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        547..590
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   REGION          323..357
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           275..281
FT                   /note="Basolateral sorting signal"
FT   COMPBIAS        323..352
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         385
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9ERZ3"
FT   CARBOHYD        5
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        6
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        15
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        41
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        48
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        141..221
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00521"
FT   DISULFID        517..520
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00521"
FT   VARIANT         65
FT                   /note="V -> I (in dbSNP:rs2067481)"
FT                   /id="VAR_033461"
FT   VARIANT         431
FT                   /note="L -> P (in dbSNP:rs16839102)"
FT                   /id="VAR_049368"
FT   MUTAGEN         276
FT                   /note="E->A: Loss of basolateral sorting."
FT                   /evidence="ECO:0000269|PubMed:15870063"
FT   MUTAGEN         276
FT                   /note="E->D: Loss of basolateral sorting. No effect on
FT                   basolateral sorting; when associated with L-280 and L-281."
FT                   /evidence="ECO:0000269|PubMed:15870063"
FT   MUTAGEN         280
FT                   /note="F->A: Loss of basolateral sorting."
FT                   /evidence="ECO:0000269|PubMed:15870063"
FT   MUTAGEN         280
FT                   /note="F->L: No effect on basolateral sorting."
FT                   /evidence="ECO:0000269|PubMed:15870063"
FT   MUTAGEN         281
FT                   /note="V->A: Loss of basolateral sorting."
FT                   /evidence="ECO:0000269|PubMed:15870063"
FT   MUTAGEN         281
FT                   /note="V->L: No effect on basolateral sorting."
FT                   /evidence="ECO:0000269|PubMed:15870063"
FT   CONFLICT        382..384
FT                   /note="KLP -> RLS (in Ref. 7; AAG30036)"
FT                   /evidence="ECO:0000305"
FT   STRAND          280..283
FT                   /evidence="ECO:0007829|PDB:2CSA"
SQ   SEQUENCE   590 AA;  66128 MW;  5CB473C57B9526E9 CRC64;
     MTLHNNSTTS PLFPNISSSW IHSPSDAGLP PGTVTHFGSY NVSRAAGNFS SPDGTTDDPL
     GGHTVWQVVF IAFLTGILAL VTIIGNILVI VSFKVNKQLK TVNNYFLLSL ACADLIIGVI
     SMNLFTTYII MNRWALGNLA CDLWLAIDYV ASNASVMNLL VISFDRYFSI TRPLTYRAKR
     TTKRAGVMIG LAWVISFVLW APAILFWQYF VGKRTVPPGE CFIQFLSEPT ITFGTAIAAF
     YMPVTIMTIL YWRIYKETEK RTKELAGLQA SGTEAETENF VHPTGSSRSC SSYELQQQSM
     KRSNRRKYGR CHFWFTTKSW KPSSEQMDQD HSSSDSWNNN DAAASLENSA SSDEEDIGSE
     TRAIYSIVLK LPGHSTILNS TKLPSSDNLQ VPEEELGMVD LERKADKLQA QKSVDDGGSF
     PKSFSKLPIQ LESAVDTAKT SDVNSSVGKS TATLPLSFKE ATLAKRFALK TRSQITKRKR
     MSLVKEKKAA QTLSAILLAF IITWTPYNIM VLVNTFCDSC IPKTFWNLGY WLCYINSTVN
     PVCYALCNKT FRTTFKMLLL CQCDKKKRRK QQYQQRQSVI FHKRAPEQAL
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024